Antunes, Natalícia de Jesus 
; Moreira, Fernanda de Lima ; Kipper, Karin ; Couchman, Lewis ; Lebre, Daniel Temponi ; Johnston, Atholl ; De Nucci, Gilberto
Source: Pharmaceuticals. Unidade: ICB
Subjects: FARMACOLOGIA, CITOCROMO P-450, ENZIMAS OXIRREDUTORAS, ANTIFÚNGICOS, INTERAÇÃO DE MEDICAMENTOS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTUNES, Natalícia de Jesus et al. Prospective prediction of Dapaconazole Clinical Drug–Drug interactions using an in vitro to in vivo extrapolation equation and PBPK modeling. Pharmaceuticals, v. 16, n. 1, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.3390/ph16010028. Acesso em: 03 maio 2024.APA
Antunes, N. de J., Moreira, F. de L., Kipper, K., Couchman, L., Lebre, D. T., Johnston, A., & De Nucci, G. (2023). Prospective prediction of Dapaconazole Clinical Drug–Drug interactions using an in vitro to in vivo extrapolation equation and PBPK modeling. Pharmaceuticals, 16( 1), 1-15. doi:10.3390/ph16010028NLM
Antunes N de J, Moreira F de L, Kipper K, Couchman L, Lebre DT, Johnston A, De Nucci G. Prospective prediction of Dapaconazole Clinical Drug–Drug interactions using an in vitro to in vivo extrapolation equation and PBPK modeling [Internet]. Pharmaceuticals. 2023 ; 16( 1): 1-15.[citado 2024 maio 03 ] Available from: https://doi.org/10.3390/ph16010028Vancouver
Antunes N de J, Moreira F de L, Kipper K, Couchman L, Lebre DT, Johnston A, De Nucci G. Prospective prediction of Dapaconazole Clinical Drug–Drug interactions using an in vitro to in vivo extrapolation equation and PBPK modeling [Internet]. Pharmaceuticals. 2023 ; 16( 1): 1-15.[citado 2024 maio 03 ] Available from: https://doi.org/10.3390/ph16010028
